Pilar Lauzurica

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Diabetic Retinopathy

Monoclonal Antibody

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Journal of virology

This page only lists publications with an associated author ORCID identifier.

Publications

Thiago Alves da Costa, Jacob N Peterson, Julie Lang, Jeremy Shulman, Xiayuan Liang, Brian M Freed, Susan A Boackle, Pilar Lauzurica, Raul M Torres, Roberta Pelanda
Central human B cell tolerance manifests with a distinctive cell phenotype and is enforced via CXCR4 signaling in hu-mice. Proceedings of the National Academy of Sciences of the United States of America 118 (16) (2021)
Laura Notario, Jennifer Redondo-Antón, Elisenda Alari-Pahissa, Almudena Albentosa, Magdalena Leiva, Daniel López, Guadalupe Sabio, Pilar Lauzurica
CD69 Targeting Enhances Anti-vaccinia Virus Immunity. Journal of virology 93 (19) (2019)
Miguel G Fontela, Laura Notario, Elisenda Alari-Pahissa, Elena Lorente, Pilar Lauzurica
The Conserved Non-Coding Sequence 2 (CNS2) Enhances CD69 Transcription through Cooperation between the Transcription Factors Oct1 and RUNX1. Genes 10 (9) (2019)
Laura Notario, Elisenda Alari-Pahissa, Almudena Albentosa, Magdalena Leiva, Guadalupe Sabio, Pilar Lauzurica
Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR. Leukemia 32 (6) (2018)